A standalone experiment was performed for comparison of the chimeric vaccine with the randomised vaccine, focusing the properties of the antigenicity and instability index (II) that were found to be varying. The randomisation of vaccine paved a way to use the random epitopes in the vaccine that can variably cause different kinds of immune response when encountered by the human body.